GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
36.50
-0.05 (-0.14%)
Mar 27, 2026, 9:03 AM CST
GeneFerm Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 280.26 | 122.45 | 120.15 | 100.69 | 539.61 |
Cash & Short-Term Investments | 280.26 | 122.45 | 120.15 | 100.69 | 539.61 |
Cash Growth | 128.88% | 1.91% | 19.33% | -81.34% | 55.05% |
Accounts Receivable | 97.93 | 101.56 | 117.6 | 120.98 | 104.66 |
Other Receivables | 15.83 | 15.22 | 0.15 | 0.46 | 0.24 |
Receivables | 113.76 | 116.78 | 117.75 | 121.44 | 104.9 |
Inventory | 190.23 | 165.87 | 155.43 | 142.61 | 114.83 |
Prepaid Expenses | 11.23 | 6.87 | 3.8 | 8.81 | 5.84 |
Total Current Assets | 595.48 | 411.97 | 397.13 | 373.54 | 765.18 |
Property, Plant & Equipment | 663.58 | 708.46 | 761.95 | 734.28 | 510.39 |
Other Intangible Assets | 1.16 | 1.7 | 2.02 | 1.1 | 1.4 |
Long-Term Deferred Tax Assets | 9.88 | 14.37 | 8.87 | 8.66 | 7.7 |
Other Long-Term Assets | 10.55 | 9.99 | 5.41 | 72.05 | 32.22 |
Total Assets | 1,281 | 1,146 | 1,175 | 1,190 | 1,317 |
Accounts Payable | 16.15 | 23.77 | 33.2 | 49.93 | 39.08 |
Accrued Expenses | - | 46.71 | 58.39 | 51.9 | 40.95 |
Short-Term Debt | - | - | 40 | 45 | - |
Current Portion of Long-Term Debt | 33.16 | 24.43 | 5.25 | 26 | 308.65 |
Current Portion of Leases | 6.26 | 5.42 | 6.04 | 5.97 | 5.19 |
Current Income Taxes Payable | 1.82 | - | 19.01 | 10.28 | 13.42 |
Current Unearned Revenue | 23.95 | 12.49 | 5.78 | 7.63 | 8.29 |
Other Current Liabilities | 77.31 | 21.43 | 22.18 | 42.52 | 15.6 |
Total Current Liabilities | 158.64 | 134.26 | 189.86 | 239.22 | 431.18 |
Long-Term Debt | 205.38 | 126.54 | - | 5.25 | 31.25 |
Long-Term Leases | 79.44 | 78.53 | 76.15 | 98.8 | 92.13 |
Pension & Post-Retirement Benefits | - | 18.88 | 16.52 | 15.59 | 14.66 |
Long-Term Deferred Tax Liabilities | 0.01 | 0.1 | - | - | - |
Other Long-Term Liabilities | 20.53 | 0.01 | 0.01 | 0.01 | 0.01 |
Total Liabilities | 464 | 358.31 | 282.54 | 358.86 | 569.22 |
Common Stock | 414.6 | 414.6 | 414.6 | 414.6 | 407.89 |
Additional Paid-In Capital | 294.34 | 294.34 | 294.34 | 294.34 | 270.69 |
Retained Earnings | 109.84 | 81.38 | 186.69 | 124.26 | 72.27 |
Comprehensive Income & Other | -2.11 | -2.13 | -2.79 | -2.43 | -3.19 |
Shareholders' Equity | 816.66 | 788.18 | 892.84 | 830.77 | 747.66 |
Total Liabilities & Equity | 1,281 | 1,146 | 1,175 | 1,190 | 1,317 |
Total Debt | 324.23 | 234.92 | 127.44 | 181.02 | 437.22 |
Net Cash (Debt) | -43.97 | -112.47 | -7.29 | -80.33 | 102.39 |
Net Cash Per Share | -1.07 | -2.71 | -0.18 | -1.89 | 2.21 |
Filing Date Shares Outstanding | 40.55 | 41.46 | 41.46 | 41.46 | 40.79 |
Total Common Shares Outstanding | 40.55 | 41.46 | 41.46 | 41.46 | 40.79 |
Working Capital | 436.85 | 277.71 | 207.27 | 134.32 | 334 |
Book Value Per Share | 20.14 | 19.01 | 21.53 | 20.04 | 18.33 |
Tangible Book Value | 815.5 | 786.48 | 890.82 | 829.67 | 746.27 |
Tangible Book Value Per Share | 20.11 | 18.97 | 21.49 | 20.01 | 18.30 |
Land | - | 15.44 | 15.44 | 15.44 | 15.44 |
Buildings | - | 457.26 | 260.87 | 259.44 | 255.46 |
Machinery | - | 825.29 | 822.26 | 725.62 | 536.67 |
Construction In Progress | - | - | 194.02 | 184.12 | 127.34 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.